Abnormal renal, hepatic, and muscle glucose metabolism following glucose ingestion in type 2 diabetes

American Journal of Physiology - Endocrinology and Metabolism

Volumn 287, Issue 6 50-6, 2004, Pages

  Meyer, Christian ^a,b   Woerle, Hans J ^a   Dostou, Jean M ^a   Welle, Stephen L ^a   Gerich, John E ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

^b CARL T HAYDEN VA MEDICAL CENTER   (United States)

Author keywords

Gluconeogenesis; Kidney; Liver; Meal

Indexed keywords

GLUCOSE;

ADULT; ARTERIAL BLOOD; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GLUCAGON BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE INTAKE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; INSULIN BLOOD LEVEL; KIDNEY METABOLISM; LIVER METABOLISM; MALE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; PRIORITY JOURNAL; SKELETAL MUSCLE;

ADMINISTRATION, ORAL; ARTERIES; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FOREARM; GLUCONEOGENESIS; GLUCOSE; HUMANS; INSULIN; KIDNEY; LIVER; MALE; MIDDLE AGED; MUSCLE, SKELETAL; OSMOLAR CONCENTRATION;

EID: 8544226262     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00041.2004     Document Type: Article

References (58)

1. Abumrad N, Rabin D, Diamond M, and Lacy W. Use of a heated superficial hand vein as an alternate site for the measurement of amino acid concentrations and for the study of glucose and alanine kinetics in man. Metabolism 30: 936-940, 1981.
2. Biava C, Grossman A, and West M. Ultrastructural observations on renal glycogen in normal and pathologic human kidneys. Lab Invest 15: 330-356, 1966.
3. Borchgrevink C and Havel R. Transport of glycerol in human blood. Proc Soc Exp Biol Med 133: 946-949, 1963.
4. Brun C. A rapid method for the determination of para-aminohippuric acid in kidney function tests. J Lab Clin Med 37: 955-958, 1951.
5. Butler P and Rizza R. Contribution to postprandial hyperglycemia and effect on initial splanchnic glucose clearance of hepatic glucose cycling in glucose-intolerant or NIDDM patients. Diabetes 40: 73-81, 1991.
6. Carlson MG, Snead WL, Hill JO, Nurjhan N, and Campbell PJ. Glucose regulation of lipid metabolism in humans. Am J Physiol Endocrinol Metab 261: E815-E820, 1991.
7. Cersosimo E, Garlick P, and Ferretti J. Insulin regulation of renal glucose metabolism in humans. Am J Physiol Endocrinol Metab 276: E78-E84, 1999.
8. Chiasson J, Liljenquist J, Lacy W, Jennings A, and Cherrington A. Gluconeogenesis: methodological approaches in vivo. Fed Proc 36: 229-235, 1977.
9. Chiasson J, Liljenquist J, Sinclair-Smith B, and Lacy W. Gluconeogenesis from alanine in normal postabsorptive man: intrahepatic stimulatory effect of glucagon. Diabetes 24: 574-584, 1975.
10. Clutter W and Cryer P. Hypoglycemia. In: Internal Medicine (4th ed.), edited by Stein J. St. Louis, MO: Mosby, 1994, p. 1424-1430.
11. Consoli A, Nurjhan N, and Gerich J. Rate of appearance and disappearance of plasma lactate after oral glucose: implications for indirect-direct pathway hepatic glycogen repletion in man. Clin Physiol Biochem 7: 70-78, 1989.
12. DeBodo R, Steele R, Dunn A, and Bishop J. On the hormonal regulation of carbohydrate metabolism: studies with 14C glucose. Rec Prog Horm Res 19: 445-448, 1963.
13. DeFronzo RA, Goldberg M, and Agus ZS. The effects of glucose and insulin on renal electrolyte transport. J Clin Invest 58: 83-90, 1976.
14. Documenta G. Scientific Tables. Ardsley, New York: Geigy Pharmaceuticals, 1962.
15. Dunlop M. Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney Int Suppl 77: S3-S12, 2000.
16. Felig P, Wahren J, and Hendler R. Influence of maturity-onset diabetes on splanchnic glucose balance after oral glucose ingestion. Diabetes 27: 121-126, 1978.
17. Ferrannini E, Wahren J, Felig P, and DeFronzo R. The role of fractional glucose extraction in the regulation of splanchnic glucose metabolism in normal and diabetic man. Metabolism 29: 28-35, 1980.
18. Firth R, Bell P, Marsh H, Hansen I, and Rizza R. Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissues. J Clin Invest 77: 1525-1532, 1986.
19. Firth R, Bell P, Marsh M, and Rizza R. Effect of tolazamide and exogenous insulin on pattern of postprandial carbohydrate metabolism in patients with noninsulin-dependent diabetes mellitus. Diabetes 36: 1130-1138, 1987.
20. Gerich J, Meyer C, Woerle HJ, and Stumvoll M. Renal gluconeogenesis: its importance in human glucose homeostasis. Diabetes Care 24: 382-391, 2001.
21. Haffner S. The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease. Endocr Rev 19: 583-592, 1998.
22. Harmon D, Britton R, and Prior R. In vitro rates of oxidation and gluconeogenesis from L(+)- and D(-)lactate in bovine tissues. Comp Biochem Physiol 77B: 365-368, 1984.
23. Heymsfield S, McManus C, Stevens V, and Smith J. Muscle mass: reliable indicator of protein-energy malnutrition seventy and outcome. Am J Clin Nutr 35: 1192-1199, 1982.
24. Kelley D, Mitrakou A, Marsh H, Schwenk F, Benn J, Sonnenberg G, Archangeli M, Aoki T, Sorensen J, Berger M, Sonksen P, and Gerich J. Skeletal muscle glycolysis, oxidation, and storage of an oral glucose load. J Clin Invest 81: 1563-1571, 1988.
25. Kelley D, Mokan M, and Veneman T. Impaired postprandial glucose utilization in non-insulin-dependent diabetes mellitus. Metabolism 43: 1549-1557, 1994.
26. Khadouri C, Barlet-Bas C, and Doucet A. Mechanism of increased tubular Na-K-ATPase during streptozotocin-induced diabetes. Pflügers Arch 409: 296-301, 1987.
27. Korner A, Eklof AC, Celsi G, and Aperia A. Increased renal metabolism in diabetes. Mechanism and functional implications. Diabetes 43: 629-633, 1994.
28. Krebs H, Speake R, and Hems R. Acceleration of renal gluconeogenesis by ketone bodies and fatty acids. Biochem J 94: 712-720, 1965.
29. Ku DD, Sellers BM, and Meezan E. Development of renal hypertrophy and increased renal Na,K-ATPase in streptozotocin-diabetic rats. Endocrinology 119: 672-679, 1986.
30. Lemieux G, Aranda M, Fournel P, and Lemieux C. Renal enzymes during experimental diabetes mellitus in the rat. Role of insulin, carbohydrate metabolism, and ketoacidosis. Can J Physiol Pharmacol 62: 70-75, 1984.
31. Liu D, Moberg E, Kollind M, Lins PE, Adamson U, and Macdonald IA. Arterial, arterialized venous, venous and capillary blood glucose measurements in normal man during hyperinsulinaemic euglycaemia and hypoglycaemia. Diabetologia 35: 287-290, 1992.
32. Ludvik B, Nolan J, Roberts A, Baloga J, Joyce M, Bell J, and Olefsky J. Evidence for decreased splanchnic glucose uptake after oral glucose administration in non-insulin-dependent diabetes mellitus. J Clin Invest 100: 2354-2361, 1997.
33. Magnusson I, Rothman D, Katz L, Shulman R, and Shulman G. Increased rate of gluconeogenesis in type II diabetes. A 13C nuclear magnetic resonance study. J Clin Invest 90: 1323-1327, 1992.
34. Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, and Turner R. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419, 1985.
35. McGuire E, Helderman J, Tobin J, Andres R, and Berman M. Effect of arterial versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol 41: 565-573, 1976.
36. McMahon M, Marsh H, and Rizza R. Effects of basal insulin supplementation on disposition of a mixed meal in obese patients with NIDDM. Diabetes 38: 291-303, 1989.
37. Meyer C, Dostou J, Nadkarni V, and Gerich J. Effects of physiological hyperinsulinemia on systemic, renal, and hepatic substrate metabolism. Am J Physiol Renal Physiol 275: F915-F921, 1998.
38. Meyer C, Dostou J, Welle S, and Gerich J. Role of human liver, kidney and skeletal muscle in postprandial glucose homeostasis. Am J Physiol Endocrinol Metab 282: E419-E427, 2002.
39. Meyer C and Gerich J. Role of the human kidney in glucose homeostasis. Curr Opin Endocrinol Diabetes 7: 19-24, 2000.
40. Meyer C, Nadkarni V, Stumvoll M, and Gerich J. Human kidney free fatty acid and glucose uptake: evidence for a renal glucose-fatty acid cycle. Am J Physiol Endocrinol Metab 273: E650-E654, 1997.
41. Meyer C, Stumvoll M, Dostou J, Welle S, Raymond M, and Gerich J. Renal substrate exchange and gluconeogenesis in normal postabsorptive humans. Am J Physiol Endocrinol Metab 282: E428-E434, 2002.
42. Meyer C, Stumvoll M, Nadkarni V, Dostou J, Mitrakou A, and Gerich J. Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus. J Clin Invest 102: 619-624, 1998.
43. Mithieux G, Vidal H, Zitoun C, Bruni N, Daniele N, and Minassean C. Glucose-6-phosphatase mRNA and activity are increased to the same extent in kidney and liver of diabetic rats. Diabetes 45: 891-896, 1996.
44. Mitrakou A, Kelley D, Veneman T, Jenssen T, Pangburn T, Reilly J, and Gerich J. Contribution of abnormal muscle and liver glucose metabolism in postprandial hyperglycemia in noninsulin-dependent diabetes mellitus. Diabetes 39: 1381-1390, 1990.
45. Moss SE, Klein R, and Klein BE. Cause-specific mortality in a population-based study of diabetes. Am J Public Health 81: 1158-1162, 1991.
46. Pehling G, Tessari P, Gerich J, Haymond M, Service F, and Rizza R. Abnormal meal carbohydrate disposition in insulin-dependent diabetes: relative contributions of endogenous glucose production and initial splanchnic uptake and effects of intensive insulin therapy. J Clin Invest 74: 985-991, 1984.
47. Radziuk J, McDonald T, Rubenstein D, and Dupre J. Initial splanchnic extraction of ingested glucose in normal man. Metabolism 27: 657-669, 1978.
48. Schleicher ED and Weigert C. Role of the hexosamine biosynthetic pathway in diabetic nephropathy. Kidney Int Suppl 77: S13-S18, 2000.
49. Schoolwerth AC and Drewnowska K. Renal metabolism. In: Diseases of the Kidney (5th ed.), edited by Schrier RW and Gottschalk CW. Boston, MA: Little Brown, 1993, p. 233-260.
50. Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, and Sekikawa A. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 22: 920-924, 1999.
51. Turner RJ and Moran A. Heterogeneity of sodium-dependent D-glucose transport sites along the proximal tubule: evidence from vesicle studies. Am J Physiol Renal Fluid Electrolyte Physiol 242: F406-F414, 1982.
52. Unger R and Orci L. Physiology and pathophysiology of glucagon. Physiol Rev 56: 779-826, 1976.
53. Wajngot A, Chandramouli V, Schumann W, Ekberg K, Jones P, Efendic S, and Landau B. Quantitative contributions of gluconeogenesis to glucose production during fasting in type 2 diabetes mellitus. Metabolism 50: 47-52, 2001.
54. +-ATPase activity. Pflügers Arch 401: 97-100, 1984.
55. Williamson J, Kreisberg R, and Felts P. Mechanism for the stimulation of gluconeogenesis by fatty acids in perfused rat liver. Proc Natl Acad Sci USA 56: 247-254, 1966.
56. Woerle HJ, Popa E, Dostou J, Welle S, Gerich J, and Meyer C. Exogenous insulin replacement in type 2 diabetes reverses excessive hepatic glucose release, but not excessive renal glucose release and impaired free fatty acid clearance. Metabolism 51: 1494-1500, 2002.
57. Wolfe R. Radioactive and Stable Isotope Tracers in Biomedicine: Principles and Practice of Kinetic Analysis. New York: Wiley-Liss, 1992.
58. World Health Organization Expert Committee. Diabetes Mellitus: A Second Report. Geneva: Technical Report Series 646, 1980.